|
C14ORF169 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.182400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.597520E-02 |
| Normal-vs-Stage2 |
8.717200E-01 |
| Normal-vs-Stage3 |
4.250200E-01 |
| Normal-vs-Stage4 |
9.041800E-02 |
| Stage1-vs-Stage2 |
2.022400E-01 |
| Stage1-vs-Stage3 |
4.913800E-01 |
| Stage1-vs-Stage4 |
2.940700E-03 |
| Stage2-vs-Stage3 |
6.198400E-01 |
| Stage2-vs-Stage4 |
8.785600E-02 |
| Stage3-vs-Stage4 |
4.981900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.889600E-02 |
| Normal-vs-AfricanAmerican |
9.323800E-02 |
| Normal-vs-Asian |
9.436200E-01 |
| Caucasian-vs-AfricanAmerican |
8.687000E-01 |
| Caucasian-vs-Asian |
7.513400E-01 |
| AfricanAmerican-vs-Asian |
6.073200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.534360E-02 |
| Normal-vs-Female |
2.018400E-01 |
| Male-vs-Female |
5.762000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.335400E-01 |
| Normal-vs-Extreme_Weight |
5.480100E-02 |
| Normal-vs-Obese |
3.062200E-01 |
| Normal-vs-Extreme_Obese |
1.333600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.386000E-01 |
| Normal_Weight-vs-Obese |
8.640200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.821400E-01 |
| Extreme_Weight-vs-Obese |
4.865600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.997600E-01 |
| Obese-vs-Extreme_Obese |
2.380400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.411000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.515800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.423830E-01 |
| Normal-vs-Age(81-100Yrs) |
9.053000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.121400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.524400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.739000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.698400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.022800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.902600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.997600E-04 |
| Normal-VS-Type2 PRCC |
2.774800E-01 |
| Normal-VS-KIRP CIMP |
6.764200E-03 |
| Normal-VS-Unclassified PRCC |
1.273820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.268000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.62149996049988E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
2.950000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.221100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.971600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.99047999999147E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.840200E-01 |
| Normal-vs-N1 |
7.254800E-01 |
| Normal-vs-N2 |
1.362240E-03 |
| N0-vs-N1 |
8.563600E-01 |
| N0-vs-N2 |
1.989500E-02 |
| N1-vs-N2 |
5.850200E-02 |
|
|
